1219936-33-0Relevant articles and documents
NEW CRTH2 ANTAGONISTS
-
Page/Page column 80, (2013/03/26)
The present invention relates to compounds of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.
HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
-
Page/Page column 16, (2010/04/25)
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.